Elizabeth A. Giuliano

Learn More
OBJECTIVE To investigate the efficacy of topical 0.2% hyaluronic acid in canine corneal ulcers in vivo. PROCEDURES Six purpose-bred beagles were randomly assigned into two groups (three dogs/group): group A received experimental product (Optimend™ , containing 0.2% hyaluronic acid, KineticVet™ ); group B received control product (Optimend™ without 0.2%(More)
Corneal scarring is due to aberrant activity of the transforming growth factor β (TGFβ) signaling pathway following traumatic, mechanical, infectious, or surgical injury. Altered TGFβ signaling cascade leads to downstream Smad (Suppressor of mothers against decapentaplegic) protein-mediated signaling events that regulate expression of extracellular matrix(More)
  • 1